Eduardo François NutritionLongevity and lifestyleEvidence in context
Clear, referenced articles on longevity, metabolic health, body composition and habits. Brazilian food-based thinking in dialogue with international science.
Published library
25 articlesIn-person nutrition consultations in Brasília and online support in English, focused on longevity, metabolic health, weight management and sustainable habits.
Evidence-based nutrition and lifestyle strategies to support vitality, autonomy and quality of life over time.
Nutrition support for weight management with attention to metabolic health, behaviour, body composition and sustainable outcomes.
Learn how nutrition, physical activity and body composition fit into evidence-based support for insulin resistance.
Nutrition care for metabolic syndrome with an integrated view of glucose, blood pressure, lipids, waist circumference and daily habits.
Nutrition support during medically prescribed GLP-1 therapy, with attention to intake, tolerance, lean mass and longer-term health.
Nutrition for muscle building and body composition with an individual strategy for energy, protein, training, recovery and routine.
How nutrition, resistance training and routine can support muscle health, autonomy and quality of life as we age.
Practical nutrition strategies to turn intention into realistic habits through clear goals, context and follow-up.
Online nutrition consultations in English for people seeking an evidence-based, practical and culturally aware approach to health and lifestyle.
The Brazilian PRAMEV trial shows why adherence, context and follow-up can reshape lifestyle-program outcomes.
OASIS-5 is studying lower maintenance doses, but it does not yet provide evidence for self-directed microdosing.
Promising research must be separated from commercial claims made by microbiome tests.
Availability, access and food-service design can make healthier choices easier at work.
A Cochrane review finds modest benefits, but no universally superior form of exercise.
Understand the regulatory differences between generic, branded similar, compounded and illegally imported semaglutide products in Brazil.
Smartwatches and smart rings may track trends, but they do not replace clinical tests or validate unsupported glucose, oxygen, blood pressure or diagnostic claims.
Understand Brazil's Anvisa notification rules for dietary supplements, the 2026 transition deadline and what regulatory status does—and does not—prove.
STEP Young found a substantial BMI reduction in children with obesity, but the results remain preliminary and do not support self-medication.
TRIUMPH-1 and TRIUMPH-2 found substantial weight loss with retatrutide, but the medicine remains investigational and products sold online are not regulated versions of the treatment.
CagriSema produced greater weight loss than tirzepatide in a phase 3 trial, but the comparator dose limits how broadly the result can be interpreted.
An outbreak linked to injectable glutathione highlights contamination risks and helps separate legitimate intravenous care from unsupported detox, immunity and energy claims.
A meta-analysis found small differences in weight and body mass index with genetics-based advice, but it did not validate the promise of a perfect DNA diet.
A network meta-analysis compared dietary strategies for paediatric metabolic dysfunction-associated steatotic liver disease, but the evidence does not identify a clear winner.
The COURAGE trial found less lean-mass and muscle-volume loss when trevogrumab was added to semaglutide, but functional benefit has not yet been established.
Individual care